Vladimir Novotny1, Michael Froehner2, Rainer Koch3, Stefan Zastrow2, Ulrike Heberling2, Steffen Leike2, Matthias Hübler4, Manfred P Wirth2. 1. Department of Urology, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. Vladimir.Novotny@uniklinikum-dresden.de. 2. Department of Urology, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. 3. Department of Medical Statistics and Biometry, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. 4. Department of Anesthesiology, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
Abstract
PURPOSE: Radical cystectomy (RC) is a major surgical procedure accompanied with meaningful complications and countable perioperative mortality. To identify the risk factors predicting the perioperative morbidity and mortality is essential. The study aimed to identify relevant, patient-specific factors associated with 90-day mortality following RC, which may serve as a foundation for improving healthcare delivery to patients with bladder cancer. METHODS: We investigated a sample of 1015 consecutive patients in order to identify predictors of 90-day mortality after RC. Beside tumor-related parameters, ASA classification, NYHA, Canadian Cardiovascular Society classification of angina pectoris, Charlson score, age, gender and the single conditions contributing to the Charlson score were included in the multivariable analyses. The patient data were collected retrospectively, except the ASA score that was obtained prospectively. RESULTS: We identified a model containing the parameters age (OR 1.05, p = 0.023), ASA classification of 3-4 (OR 6.19, p < 0.001) and Charlson score (OR 1.22, p = 0.003) to predict 90-day mortality. Among the single conditions to the Charlson score, moderate or severe renal disease (OR 3.94, p < 0.001) and liver disease (OR 3.24, p = 0.037) were most closely related to 90-day mortality. CONCLUSIONS: Age, ASA classification and Charlson score as well as moderate or severe renal disease and liver disease appear to be independent predictors of 90-day mortality after RC. Given the highly significant association of ASA score with 90-day mortality and the relative ease and width disposability of this measure, this classification should be, after external validation, incorporated into daily clinical practice in treatment of patients planned to RC.
PURPOSE: Radical cystectomy (RC) is a major surgical procedure accompanied with meaningful complications and countable perioperative mortality. To identify the risk factors predicting the perioperative morbidity and mortality is essential. The study aimed to identify relevant, patient-specific factors associated with 90-day mortality following RC, which may serve as a foundation for improving healthcare delivery to patients with bladder cancer. METHODS: We investigated a sample of 1015 consecutive patients in order to identify predictors of 90-day mortality after RC. Beside tumor-related parameters, ASA classification, NYHA, Canadian Cardiovascular Society classification of angina pectoris, Charlson score, age, gender and the single conditions contributing to the Charlson score were included in the multivariable analyses. The patient data were collected retrospectively, except the ASA score that was obtained prospectively. RESULTS: We identified a model containing the parameters age (OR 1.05, p = 0.023), ASA classification of 3-4 (OR 6.19, p < 0.001) and Charlson score (OR 1.22, p = 0.003) to predict 90-day mortality. Among the single conditions to the Charlson score, moderate or severe renal disease (OR 3.94, p < 0.001) and liver disease (OR 3.24, p = 0.037) were most closely related to 90-day mortality. CONCLUSIONS: Age, ASA classification and Charlson score as well as moderate or severe renal disease and liver disease appear to be independent predictors of 90-day mortality after RC. Given the highly significant association of ASA score with 90-day mortality and the relative ease and width disposability of this measure, this classification should be, after external validation, incorporated into daily clinical practice in treatment of patients planned to RC.
Authors: Evi Comploj; Jeremy West; Michael Mian; Luis Alex Kluth; Alexander Karl; Christopher Dechet; Shahrokh F Shariat; Christian G Stief; Emanuela Trenti; Salvatore Palermo; Michele Lodde; Wolfgang Horninger; Stephan Madersbacher; Armin Pycha Journal: Urol Int Date: 2014-06-24 Impact factor: 2.089
Authors: Giorgio Gandaglia; Briony Varda; Akshay Sood; Daniel Pucheril; Ramdev Konijeti; Jesse D Sammon; Shyam Sukumar; Mani Menon; Maxine Sun; Steven L Chang; Francesco Montorsi; Adam S Kibel; Quoc-Dien Trinh Journal: Can Urol Assoc J Date: 2014-09 Impact factor: 1.862
Authors: Atiqullah Aziz; Matthias May; Maximilian Burger; Rein-Jüri Palisaar; Quoc-Dien Trinh; Hans-Martin Fritsche; Michael Rink; Felix Chun; Thomas Martini; Christian Bolenz; Roman Mayr; Armin Pycha; Philipp Nuhn; Christian Stief; Vladimir Novotny; Manfred Wirth; Christian Seitz; Joachim Noldus; Christian Gilfrich; Shahrokh F Shariat; Sabine Brookman-May; Patrick J Bastian; Stefan Denzinger; Michael Gierth; Florian Roghmann Journal: Eur Urol Date: 2013-12-27 Impact factor: 20.096
Authors: Jeffrey J Leow; Stephen Reese; Quoc-Dien Trinh; Joaquim Bellmunt; Benjamin I Chung; Adam S Kibel; Steven L Chang Journal: BJU Int Date: 2015-01-26 Impact factor: 5.588
Authors: J Schiffmann; G Gandaglia; A Larcher; M Sun; Z Tian; S F Shariat; M McCormack; L Valiquette; F Montorsi; M Graefen; F Saad; P I Karakiewicz Journal: Eur J Surg Oncol Date: 2014-10-15 Impact factor: 4.424
Authors: Matthew E Nielsen; Katherine Mallin; Mark A Weaver; Bryan Palis; Andrew Stewart; David P Winchester; Matthew I Milowsky Journal: BJU Int Date: 2014-05-22 Impact factor: 5.588
Authors: Marianne Schmid; Michael Rink; Miriam Traumann; Patrick J Bastian; Georg Bartsch; Jörg Ellinger; Marc-Oliver Grimm; Boris Hadaschik; Axel Haferkamp; Oliver W Hakenberg; Atiqullah Aziz; Florian Hartmann; Edwin Herrmann; Markus Hohenfellner; Günter Janetschek; Michael Gierth; Sasc ha Pahernik; Chris Protzel; Jan Roigas; Murat Gördük; Lukas Lusuardi; Matthias May; Quoc-Dien Trinh; Margit Fisch; Felix K H Chun Journal: Ann Surg Oncol Date: 2014-08-28 Impact factor: 5.344
Authors: C De Nunzio; L Cindolo; C Leonardo; A Antonelli; C Ceruti; G Franco; M Falsaperla; M Gallucci; M Alvarez-Maestro; A Minervini; V Pagliarulo; P Parma; S Perdonà; A Porreca; B Rocco; L Schips; S Serni; M Serrago; C Simeone; G Simone; R Spadavecchia; A Celia; P Bove; S Zaramella; S Crivellaro; R Nucciotti; A Salvaggio; B Frea; V Pizzuti; L Salsano; A Tubaro Journal: Eur J Surg Oncol Date: 2013-04-04 Impact factor: 4.424
Authors: Roman Mayr; Hans-Martin Fritsche; Florian Zeman; Marieke Reiffen; Leopold Siebertz; Christoph Niessen; Armin Pycha; Bas W G van Rhijn; Maximilian Burger; Michael Gierth Journal: World J Urol Date: 2018-03-08 Impact factor: 4.226
Authors: Sophia Liff Maibom; Ulla Nordström Joensen; Alicia Martin Poulsen; Henrik Kehlet; Klaus Brasso; Martin Andreas Røder Journal: BMJ Open Date: 2021-04-14 Impact factor: 2.692